We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...

Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PLEASANTON, CA—Alan Mateo, a director at 10x Genomics, Inc. (NASDAQ:TXG), has recently increased his stake in the company.... In a turbulent market environment, 10X Genomics Inc (NASDAQ:TXG) ...

Cathie Wood's ARK ETFs have made a series of trades on Tuesday, April 9, 2024, as part of their regular portfolio adjustments. The ...

Investing.com - 10X Genomics (NASDAQ: TXG) reported second quarter EPS of $-0.53, $0.13 worse than the analyst estimate of $-0.40.

Is now the time to buy 10x Genomics, or should you be careful about ... Here are three reasons why there are better opportunities than TXG and a stock we'd rather own. Free cash flow isn't a ...